ArticleJournal of translational medicine2021

Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy.

Yajun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.